ARCHIVES

Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Kennedy Chooses Health/Education Chair Over Judiciary; No Major Changes In Senate Cancer Policies Expected

November 14, 1986

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992

Control AC Hear Report On High Risk conference, Messer Survey

September 6, 1974

Kaiser Foundation Offers Community Health Grants

April 18, 1986

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001